This is my archive

GIFTT: The Guaranteed Income and Financial Treatment Trial

Project Description Financial hardships impact one in three patients during the course of their cancer treatment, and are experienced more severely by women, people of color, and low-income families.

First Intervention on Financial Toxicity in Gynecologic Oncology

Project Description Gynecologic cancers are the third most common cancer in the United States. While advances such as multi-modal therapeutics have had a positive impact on care and overall…

Pioneering Radiation Oncology Episode Payment

Project Description Whereas payment for radiotherapy treatment has historically been fee-for-service, Penn Medicine has pioneered episode-based payment: bundling payments for radiation services within a defined period of care as…

Financial Navigation Program for Patients with Multiple Myeloma

Project Description Multiple myeloma is a cancer of the plasma cells which is currently incurable and often requires systemic therapy for the duration of a patient’s life–which for one…

Text Messaging and Take-At-Home Tests Boost Colorectal Cancer Screening

Project Description By providing the opportunity for early discovery and curative treatment, regular screenings have been shown to reduce mortality rates for colorectal cancer (CRC). Unfortunately, regular screening rates…

Impact of Insurance Coverage on Clinical Trial Enrollment

Project Description Cancer clinical trials have vital benefits: evaluating the safety of new therapies, establishing new standards of care, and, in some cases, prolonging patients’ lives. However, members of…

IMPACT: Improving Access to Cancer Clinical Trials

Project Description Lazarex Cancer Foundation established a pilot financial reimbursement program in 2013 aiming to remove financial barriers to clinical trial participation for patients with cancer. There was a…

Nudges Informed by Behavioral Economics to Increase Utilization of Higher-Value Cancer Drugs

Project Description Identifying effective ways to promote high-value, evidence-based prescribing is particularly important in cancer care, where spending is estimated to surpass $170 billion by 2020, driven in large…

Direct and Spillover Impact of Utilization Management Policy on Uptake of Hypofractionated Radiation in Early-Stage Breast Cancer

Project Description Breast cancer accounts for the largest portion of cancer-related spending in the United States. Prior work has shown that while hypofractionated radiation following breast conservation surgery is…

Characteristics of Physicians Participating in Medicare’s Oncology Care Model Bundled Payment Program

Project Description The Oncology Care Model (OCM) is Medicare’s first bundled payment program for patients with cancer. PC3I Researchers examined baseline characteristics of OCM physician participants and markets with…